# Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

> **NCT04070378** · PHASE2 · COMPLETED · sponsor: **Marc L Gordon, MD** · enrollment: 16 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Daratumumab Injection

## Key facts

- **NCT ID:** NCT04070378
- **Lead sponsor:** Marc L Gordon, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-06
- **Primary completion:** 2023-06-08
- **Final completion:** 2023-08-15
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04070378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04070378, "Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04070378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*